Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats. [PDF]
Zeytinoglu M +9 more
europepmc +1 more source
Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database. [PDF]
Guan S +8 more
europepmc +1 more source
Current and emerging therapeutic strategies for amyotrophic lateral sclerosis: from pharmacological approaches to gene and stem cell therapies. [PDF]
Wang Z, Huang J, Yun D.
europepmc +1 more source
Spinal cord-protective effect of resorcimoline for ischemia-reperfusion injury in a rabbit model. [PDF]
Kawahara Y +10 more
europepmc +1 more source
Edaravone in the treatment of amyotrophic lateral sclerosis
openaire +2 more sources
Efficacy and safety of edaravone dexborneol in acute ischemic stroke: systematic review and meta-analysis. [PDF]
Moghib K +6 more
europepmc +1 more source
Frontiers and Emerging Trends in Edaravone Research: A Bibliometric Analysis of Molecular Basis and Clinical Studies Using CiteSpace and VOSviewer. [PDF]
Sun LC +6 more
europepmc +1 more source
Edaravone dextrocamphorol combined with intravenous thrombolysis enhances recovery in acute ischemic stroke. [PDF]
Wei B, Ji G, Fang L, Shi W.
europepmc +1 more source
Real-world safety and tolerability of intravenous edaravone in patients with amyotrophic lateral sclerosis. [PDF]
Abrahao A +3 more
europepmc +1 more source
Elucidating multifaceted targets of Marein in cerebral ischemia-reperfusion injury. [PDF]
Luo W +15 more
europepmc +1 more source

